Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Fanuc Corporation | 2.62% | $476.83K | ¥5.28T | 49.62% | 74 Outperform | |
| Roche Holding AG | 2.38% | $431.78K | CHF260.13B | 48.38% | 73 Outperform | |
| Baidu, Inc. Class A | 2.35% | $426.88K | HK$326.72B | 42.28% | 63 Neutral | |
| GlaxoSmithKline | 2.34% | $425.06K | £73.51B | 35.68% | 77 Outperform | |
| HOYA | 2.28% | $414.61K | ¥8.16T | 21.41% | 74 Outperform | |
| US Bancorp | 2.24% | $407.12K | $84.19B | 13.56% | 76 Outperform | |
| Bristol-Myers Squibb | 2.20% | $399.38K | $110.32B | -5.37% | 78 Outperform | |
| Yum China Holdings | 2.12% | $385.30K | $17.50B | -0.27% | 78 Outperform | |
| Tencent Holdings | 2.09% | $379.25K | HK$5.56T | 48.30% | 75 Outperform | |
| ― | 1.99% | $361.47K | ― | ― | ― |